v3.26.3
Condensed Consolidated Statements of Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Total Palantir’s Stockholders’ Equity
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income, Net
Accumulated Deficit
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2024     2,338,795        
Beginning balance at Dec. 31, 2024 $ 5,094,407 $ 5,003,275 $ 2,339 $ 10,193,970 $ (5,611) $ (5,187,423) $ 91,132
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock from the exercise of stock options (in shares)     23,992        
Issuance of common stock from the exercise of stock options 120,839 120,839 $ 23 120,816      
Issuance of common stock upon release of restricted stock units (“RSUs”) and performance-based RSUs (“P-RSUs”) (in shares)     21,022        
Issuance of common stock upon release of restricted stock units (“RSUs”) and performance-based RSUs (“P-RSUs”)     $ 21 (21)      
Repurchases of common stock (in shares)     (495)        
Repurchases of common stock (55,789) (55,789)   (55,789)      
Stock-based compensation 488,627 488,627   488,627      
Other comprehensive (loss) income 17,148 17,148     17,148    
Net income 1,023,037 1,016,357       1,016,357 6,680
Ending balance (in shares) at Sep. 30, 2025     2,383,314        
Ending balance at Sep. 30, 2025 6,688,269 6,590,457 $ 2,383 10,747,603 11,537 (4,171,066) 97,812
Beginning balance (in shares) at Jun. 30, 2025     2,371,847        
Beginning balance at Jun. 30, 2025 6,025,564 5,928,901 $ 2,372 10,568,473 4,721 (4,646,665) 96,663
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock from the exercise of stock options (in shares)     4,890        
Issuance of common stock from the exercise of stock options 25,638 25,638 $ 4 25,634      
Issuance of common stock upon release of restricted stock units (“RSUs”) and performance-based RSUs (“P-RSUs”) (in shares)     6,697        
Issuance of common stock upon release of restricted stock units (“RSUs”) and performance-based RSUs (“P-RSUs”)     $ 7 (7)      
Repurchases of common stock (in shares)     (120)        
Repurchases of common stock (19,195) (19,195)   (19,195)      
Stock-based compensation 172,698 172,698   172,698      
Other comprehensive (loss) income 6,816 6,816     6,816    
Net income 476,748 475,599       475,599 1,149
Ending balance (in shares) at Sep. 30, 2025     2,383,314        
Ending balance at Sep. 30, 2025 $ 6,688,269 6,590,457 $ 2,383 10,747,603 11,537 (4,171,066) 97,812
Beginning balance (in shares) at Dec. 31, 2025 2,391,192   2,391,192        
Beginning balance at Dec. 31, 2025 $ 7,488,011 7,387,268 $ 2,391 10,933,325 13,942 (3,562,390) 100,743
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock from the exercise of stock options (in shares) 4,782   4,782        
Issuance of common stock from the exercise of stock options $ 22,606 22,606 $ 5 22,601      
Issuance of common stock from the exercise of stock appreciation rights (“SARs”), net of shares withheld for employee taxes (in shares)     7        
Issuance of common stock from the exercise of stock appreciation rights (“SARs”), net of shares withheld for employee taxes (972) (972)   (972)      
Issuance of common stock upon release of restricted stock units (“RSUs”) and performance-based RSUs (“P-RSUs”) (in shares)     13,180        
Issuance of common stock upon release of restricted stock units (“RSUs”) and performance-based RSUs (“P-RSUs”)     $ 13 (13)      
Repurchases of common stock (in shares)     (8)        
Repurchases of common stock (1,500) (1,500)   (1,500)      
Stock-based compensation 786,527 786,527   786,527      
Other comprehensive (loss) income (26,377) (26,377)     (26,377)    
Net income $ 3,076,805 3,060,429       3,060,429 16,376
Ending balance (in shares) at Sep. 30, 2026 2,409,153   2,409,153        
Ending balance at Sep. 30, 2026 $ 11,345,100 11,227,981 $ 2,409 11,739,968 (12,435) (501,961) 117,119
Beginning balance (in shares) at Jun. 30, 2026     2,402,897        
Beginning balance at Jun. 30, 2026 9,884,884 9,774,194 $ 2,403 11,408,867 (7,103) (1,629,973) 110,690
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock from the exercise of stock options (in shares)     2,715        
Issuance of common stock from the exercise of stock options 12,849 12,849 $ 3 12,846      
Issuance of common stock from the exercise of stock appreciation rights (“SARs”), net of shares withheld for employee taxes (in shares)     7        
Issuance of common stock from the exercise of stock appreciation rights (“SARs”), net of shares withheld for employee taxes (972) (972)   (972)      
Issuance of common stock upon release of restricted stock units (“RSUs”) and performance-based RSUs (“P-RSUs”) (in shares)     3,534        
Issuance of common stock upon release of restricted stock units (“RSUs”) and performance-based RSUs (“P-RSUs”)     $ 3 (3)      
Stock-based compensation 319,230 319,230   319,230      
Other comprehensive (loss) income (5,332) (5,332)     (5,332)    
Net income $ 1,134,441 1,128,012       1,128,012 6,429
Ending balance (in shares) at Sep. 30, 2026 2,409,153   2,409,153        
Ending balance at Sep. 30, 2026 $ 11,345,100 $ 11,227,981 $ 2,409 $ 11,739,968 $ (12,435) $ (501,961) $ 117,119